Regulation of autophagy by bile acids and in cholestasis - CholestoPHAGY or CholeSTOPagy.
AMP-Activated Protein Kinases
/ metabolism
Animals
Autophagosomes
/ drug effects
Autophagy
/ drug effects
Bile Acids and Salts
/ metabolism
Bile Ducts
/ cytology
Cholagogues and Choleretics
/ pharmacology
Cholestasis
/ drug therapy
Disease Models, Animal
Epithelial Cells
/ metabolism
Fibric Acids
/ pharmacology
Humans
Intestinal Mucosa
/ cytology
Lipid Metabolism
/ drug effects
Liver
/ cytology
Lysosomes
/ drug effects
Non-alcoholic Fatty Liver Disease
/ drug therapy
Protein Kinase Inhibitors
/ pharmacology
Receptors, Cytoplasmic and Nuclear
/ metabolism
Signal Transduction
/ drug effects
TOR Serine-Threonine Kinases
/ antagonists & inhibitors
Autophagy
Bile acids
Cholestasis
FXR
UDCA
Journal
Biochimica et biophysica acta. Molecular basis of disease
ISSN: 1879-260X
Titre abrégé: Biochim Biophys Acta Mol Basis Dis
Pays: Netherlands
ID NLM: 101731730
Informations de publication
Date de publication:
01 02 2021
01 02 2021
Historique:
received:
20
08
2020
revised:
13
10
2020
accepted:
17
11
2020
pubmed:
27
11
2020
medline:
24
4
2021
entrez:
26
11
2020
Statut:
ppublish
Résumé
Autophagy is a lysosomal degradation pathway in which the cell self-digests its own components to provide nutrients in harsh environmental conditions. It also represents an opportunity to rid the cell of superfluous and damaged organelles, misfolded proteins or invaded microorganisms. Liver autophagy contributes to basic hepatic functions such as lipid, glycogen and protein turnover. Deregulated hepatic autophagy has been linked to many liver diseases including alpha-1-antitrypsin deficiency, alcoholic and non-alcoholic fatty liver diseases, hepatitis B and C infections, liver fibrosis as well as liver cancer. Recently, bile acids and the bile acid receptor FXR have been implicated in the regulation of hepatic autophagy, which implies a role of autophagy also for cholestatic liver diseases. This review summarizes the current evidence of bile acid mediated effects on autophagy and how this affects cholestatic liver diseases. Although detailed studies are lacking, we suggest a concept that the activity of autophagy in cholestasis depends on the disease stage, where autophagy may be induced at early stages ("cholestophagy") but may be impaired in prolonged cholestatic states ("cholestopagy").
Identifiants
pubmed: 33242590
pii: S0925-4439(20)30365-3
doi: 10.1016/j.bbadis.2020.166017
pii:
doi:
Substances chimiques
Bile Acids and Salts
0
Cholagogues and Choleretics
0
Fibric Acids
0
Protein Kinase Inhibitors
0
Receptors, Cytoplasmic and Nuclear
0
farnesoid X-activated receptor
0C5V0MRU6P
TOR Serine-Threonine Kinases
EC 2.7.11.1
AMP-Activated Protein Kinases
EC 2.7.11.31
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
166017Subventions
Organisme : Austrian Science Fund FWF
ID : P 30482
Pays : Austria
Informations de copyright
Copyright © 2020 Elsevier B.V. All rights reserved.